ARCHIVES

Evidence Too Weak to Link Agent Orange, Cancer, IOM Says

This article is from The Cancer Letter archive.

Vol. 28 No. 12 | March 22, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Approves Votrient For Soft Tissue Sarcomas

April 27, 2012

Early Treatment with CMX001 Can Help Prevent CMV Infection

September 27, 2013

Senate Appropriations Include Cancer Control, Training Money, But Very Little for Construction

July 8, 1988

ASCO Members Pick Schilsky as President-Elect; Five Elected to Society’s Board of Directors.

February 16, 2007

Colorado Researchers Study Massage To Reduce Symptoms

September 26, 2003

CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely

May 23, 2003